Demonstrates enhanced curdlan production in mutants, highlighting efficient strain screening methods.
Curdlan is an industrially important β-1,3-glucan with applications in the food, pharmaceutical, and biomaterial industries. However, the identification of high-yielding curdlan-producing strains is hindered by the absence of rapid and efficient screening methods. To address this limitation, we developed a systematically optimized integrated microscale workflow combining 48-well plate fermentation with a quantitative aniline blue-based colorimetric assay in 96-well plates for high-throughput screening of curdlan-producing strains. Fermentation was miniaturized using 48-well plates, while curdlan quantification was performed in 96-well plates through formation of a curdlan–aniline blue complex. Key parameters were systematically optimized. Under optimal conditions, curdlan dissolved in 1.0 mol/L NaOH was reacted with 2.0 mg/mL aniline blue in 0.5 mol/L phosphate buffer (pH 7.0) for 90 min, and absorbance was measured at 550 nm. The assay demonstrated excellent linearity between curdlan concentration and absorbance (y = 1.0008x + 0.1536, R2 = 0.9957, p < 0.001). To validate the method, curdlan yields from nine mutants derived from ATCC31749 were determined using both gravimetric and colorimetric approaches, revealing a strong correlation (R2 = 0.8683, p < 0.001), that confirmed the assay’s reliability for rapid screening. Application of this platform to 132 UV-mutagenized strains identified nine mutants with enhanced curdlan production. The best-performing strain, UV150824-02, produced 46.8 ± 0.08 g/L curdlan, an 11.4% increase over the wild-type strain ATCC31749 (41.6 ± 1.54 g/L), and maintained stable curdlan production over nine laboratory passages (coefficient of variation = 2.72%). This method significantly improves the efficiency of mutagenesis-based strain screening and provides a practical and efficient tool for accelerating strain improvement in industrial polysaccharide fermentation.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: